Sunday, June 21, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,771
Drugs linked 4,798

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 777 of 1,261

  1. US 8916172

    MVA expressing modified HIV envelope, gag, and pol genes

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  2. US 8916159

    Selenocysteine mediated hybrid antibody molecules

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  3. US 8916184

    Artificial tissue systems and uses thereof

    UNIVERSITY OF CONNECTICUT · Granted Dec 23, 2014 · Expires Dec 18, 2034

    granted

  4. US 2014371251

    METHOD OF INHIBITING DYRK1B

    4SC DISCOVERY GMBH [DE] · Granted Dec 18, 2014 · Expires Dec 13, 2034

    granted

  5. US 8912214

    Use of Chk2 kinase inhibitors for cancer treatment

    The United States of America, as represented by the Secretary, Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  6. US 8911722

    Modulation of yeast-based immunotherapy products and responses

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  7. US 8911742

    Transcutaneous immunization without heterologous adjuvant

    The United States of America as represented by the Secretary of the Army · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  8. US 8911752

    Methods of making compositions comprising lecithin oils and NSAIDS for protecting the gastrointestinal tract and providing enhanced therapeutic activity

    The Board of Regents of the University of Texas System · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  9. US 8912175

    Topical compositions for treatment of skin conditions

    Molecular Design International, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  10. US 8912146

    Derivatives of APF and methods of use

    The United States of America, as represented by the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  11. US 8912326

    Process of making gyrase and topoisomerase inhibitors

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  12. US 8912198

    Compounds useful as inhibitors of ATR kinase

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  13. US 8912185

    Use of glutaric acid derivatives or the pharmaceutically acceptable salts thereof as anti-arrhythmic agents

    OBSCHESTVO S OGRANICHENNOI OTVETSTVENNOSTIYU “PHARMENTERPRISES” · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  14. US 8912199

    Modulators of ATP-binding cassette transporters

    Vertex Pharmaceuticals Incorporated · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  15. US 8912316

    Compositions and methods for inhibiting expression of CD45 gene

    The Government of the United States, as Respresented by the Secretary of the Army · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  16. US 8912142

    Method of regulating proliferation and differentiation of keratinocyes

    The Medical Research, Infrastructure and Health Services Fund of the Tel-Aviv Medical Center · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  17. US 8912138

    DNA-binding proteins and uses thereof

    Sangamo Biosciences, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  18. US 8912172

    Skin external preparation containing triterpenic acid

    KURARAY CO., LTD. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  19. US 8912170

    Prodrugs of 2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  20. US 8911743

    Haemophilus parasuis polypeptides and methods of use

    Regents of the University of Minnesota · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  21. US 8911729

    Stem cell factor inhibitor

    THE REGENTS OF THE UNIVERSITY OF MICHIGAN · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  22. US 8911733

    Inhibition of the alternative complement pathway for treatment of traumatic brain injury, spinal cord injury and related conditions

    The Regents of the University of Colorado, a Body Corporate · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  23. US 8911728

    High-affinity fully functional soluble single-domain human CD4, antibodies, and related fusion proteins

    The United States of America as Represented by the Secretary of the Department of Health and Human Services · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

  24. US 8911718

    Methods for preparing polymeric reagents

    Nektar Therapeutics · Granted Dec 16, 2014 · Expires Dec 11, 2034

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.